Digital Health in Diabetes and Cardiovascular Disease

References

• Leon BM. Diabetes and cardiovascular disease: Epidemiology, biological mechanisms, treatment recommendations and future research. WJD. 2015;6(13):1246. doi:10.4239/wjd.v6.i13.1246.
   Google Scholar
• Rhee SY, Kim C, Shin DW, Steinhubl SR. Present and future of digital health in diabetes and metabolic disease. Diabetes Metab J. 2020;44(6):819–827. doi:10.4093/dmj.2020.0088.
   PubMed Web of Science ®Google Scholar
• FDA. What is digital health? FDA. https://www.fda.gov/medical-devices/digital-health-center-excellence/what-digital-health. Published September 22, 2020. Accessed December 6, 2023.
   Google Scholar
• Mathews SC, McShea MJ, Hanley CL, Ravitz A, Labrique AB, Cohen AB. Digital health: a path to validation. NPJ Digit Med. 2019;2(1):38. doi:10.1038/s41746-019-0111-3.
   PubMedGoogle Scholar
• Jin X, Cai A, Xu T, Zhang X. Artificial intelligence biosensors for continuous glucose monitoring. Int Mater. 2023;2(2):290–307. doi:10.1002/idm2.12069.
   Google Scholar
• Guan Z, Li H, Liu R, et al. Artificial intelligence in diabetes management: Advancements, opportunities, and challenges. Cell Rep Med. 2023;4(10):101213. doi:10.1016/j.xcrm.2023.101213.
   PubMedGoogle Scholar
• Rajpurkar P, Chen E, Banerjee O, Topol EJ. AI in health and medicine. Nat Med. 2022;28(1):31–38. doi:10.1038/s41591-021-01614-0.
   PubMed Web of Science ®Google Scholar
• Esteva A, Kuprel B, Novoa RA, et al. Dermatologist-level classification of skin cancer with deep neural networks. Nature. 2017;542(7639):115–118. doi:10.1038/nature21056.
   PubMed Web of Science ®Google Scholar
• Al-Halafi A. Applications of artificial intelligence-assisted retinal imaging in systemic diseases: a literature review. Saudi J Ophthalmol. 2023;37(3):185. doi:10.4103/sjopt.sjopt_153_23.
   PubMed Web of Science ®Google Scholar
• Kuziemsky C, Maeder AJ, John O, et al. Role of artificial intelligence within the telehealth domain: Official 2019 yearbook contribution by the members of IMIA telehealth working group. Yearb Med Inform. 2019;28(1):035–040. doi:10.1055/s-0039-1677897.
   PubMedGoogle Scholar
• Einarson TR, Acs A, Ludwig C, Panton UH. Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007 2017. Cardiovasc Diabetol. 2018;17(1):83. doi:10.1186/s12933-018-0728-6.
   PubMed Web of Science ®Google Scholar
• Joseph JJ, Deedwania P, Acharya T, et al. Comprehensive management of cardiovascular risk factors for adults with type 2 diabetes: a scientific statement from the American Heart Association. Circulation. 2022;145(9):e722–59. doi:10.1161/CIR.0000000000001040.
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. Economic costs of diabetes in the U.S. in 2017. Diab Care. 2018;41(5):917–928. doi:10.2337/dci18-0007.
   PubMed Web of Science ®Google Scholar
• Bakris GL. The importance of blood pressure control in the patient with diabetes. Am J Med. 2004;116(5):30–38. doi:10.1016/j.amjmed.2003.10.018.
   Google Scholar
• Ormazabal V, Nair S, Elfeky O, Aguayo C, Salomon C, Zuñiga FA. Association between insulin resistance and the development of cardiovascular disease. Cardiovasc Diabetol. 2018;17(1):122. doi:10.1186/s12933-018-0762-4.
   PubMed Web of Science ®Google Scholar
• Pistrosch F, Natali A, Hanefeld M. Is Hyperglycemia a Cardiovascular Risk Factor? Diab Care. 2011;34(Supp_2):S128–S131. doi:10.2337/dc11-s207.
   PubMedGoogle Scholar
• Bhupathiraju SN, Hu FB. Epidemiology of obesity and diabetes and their cardiovascular complications. Circ Res. 2016;118(11):1723–1735. doi:10.1161/CIRCRESAHA.115.306825.
   PubMed Web of Science ®Google Scholar
• Goldberg IJ. Diabetic dyslipidemia: Causes and consequences. J Clin Endocrinol Metab. 2001;86(3):965–971. doi:10.1210/jcem.86.3.7304.
   PubMed Web of Science ®Google Scholar
• Fiorentino T, Prioletta A, Zuo P, Folli F. Hyperglycemia-induced oxidative stress and its role in diabetes mellitus related cardiovascular diseases. CPD. 2013;19(32):5695–5703. doi:10.2174/1381612811319320005.
   Google Scholar
• Rawshani A, Rawshani A, Franzén S, et al. Risk Factors, mortality, and cardiovascular outcomes in patients with type 2 diabetes. N Engl J Med. 2018;379(7):633–644. doi:10.1056/NEJMoa1800256.
   PubMed Web of Science ®Google Scholar
• Gray R, Indraratna P, Lovell N, Ooi SY. Digital health technology in the prevention of heart failure and coronary artery disease. Cardiovasc Dig Health J. 2022;3(6):S9–S16. doi:10.1016/j.cvdhj.2022.09.002.
   PubMedGoogle Scholar
• ElSayed NA, Aleppo G, Aroda VR, et al. Summary of revisions: Standards of care in diabetes—2023. Diab Care. 2023;46(Supp_1):S5–S9. doi:10.2337/dc23-Srev.
   PubMedGoogle Scholar
• Ndumele CE, Neeland IJ, Tuttle KR, et al. A synopsis of the evidence for the science and clinical management of Cardiovascular-Kidney-Metabolic (CKM) Syndrome: A scientific statement from the American Heart Association. Circulation. October 9, 2023;148(20):1636–1664. doi:10.1161/CIR.0000000000001186.
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. 5. Facilitating behavior change and well-being to improve health outcomes: Standards of medical care in diabetes—2021. Diab Care. 2021;44(Supp_1):S53–S72. doi:10.2337/dc21-S005.
   PubMedGoogle Scholar
• American Diabetes Association. 8. Obesity management for the treatment of type 2 diabetes: Standards of medical care in diabetes—2021. Diab Care. 2021;44(Supp_1):S100–S110. doi:10.2337/dc21-S008.
   PubMedGoogle Scholar
• Liu G, Li Y, Hu Y, et al. Influence of lifestyle on incident cardiovascular disease and mortality in patients with diabetes mellitus. J Am Coll Cardiol. 2018;71(25):2867–2876. doi:10.1016/j.jacc.2018.04.027.
   PubMed Web of Science ®Google Scholar
• Kamga P, Mostafa R, Zafar S. The use of wearable ECG devices in the clinical setting: A review. Curr Emerg Hosp Med Rep. 2022;10(3):67–72. doi:10.1007/s40138-022-00248-x.
   PubMed Web of Science ®Google Scholar
• Georgousopoulou E, Panagiotakos D, Bougatsas D, et al. Physical activity level improves the predictive accuracy of cardiovascular disease risk score: The ATTICA study (2002-2012). Int J Prev Med. 2016;7(1):52. doi:10.4103/2008-7802.178346.
   PubMedGoogle Scholar
• Blond K, Brinkløv CF, Ried-Larsen M, Crippa A, Grøntved A. Association of high amounts of physical activity with mortality risk: a systematic review and meta-analysis. Br J Sports Med. 2020;54(20):1195–1201. doi:10.1136/bjsports-2018-100393.
   PubMed Web of Science ®Google Scholar
• Arnett DK, Blumenthal RS, Albert MA, et al. ACC/AHA guideline on the primary prevention of cardiovascular disease: A report of the American College of Cardiology/AmericanHeart Association Task Force on clinical practice guidelines. Circulation. 2019;140(11):e596–646. doi:10.1161/CIR.0000000000000678.
   PubMed Web of Science ®Google Scholar
• Fabbrizio A, Fucarino A, Cantoia M, et al. Smart devices for health and wellness applied to tele-exercise: an overview of new trends and technologies such as IoT and AI. Healthcare. 2023;11(12):1805. doi:10.3390/healthcare11121805.
   Web of Science ®Google Scholar
• Fox CS, Pencina MJ, Wilson PWF, Paynter NP, Vasan RS, D’Agostino RB. Lifetime risk of cardiovascular disease among individuals with and without diabetes stratified by obesity status in the Framingham Heart Study. Diab Care. 2008;31(8):1582–1584. doi:10.2337/dc08-0025.
   PubMed Web of Science ®Google Scholar
• Hubert HB, Feinleib M, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation. 1983;67(5):968–977. doi:10.1161/01.CIR.67.5.968.
   PubMed Web of Science ®Google Scholar
• Garcia-Labbé D, Ruka E, Bertrand OF, Voisine P, Costerousse O, Poirier P. Obesity and Coronary Artery Disease: Evaluation and Treatment. Can J Cardiol. 2015;31(2):184–194. doi:10.1016/j.cjca.2014.12.008.
   PubMed Web of Science ®Google Scholar
• Rossi MCE, Lucisano G, Comaschi M, et al. Quality of diabetes care predicts the development of cardiovascular events: Results of the AMD-QUASAR study. Diab Care. 2011;34(2):347–352. doi:10.2337/dc10-1709.
   PubMed Web of Science ®Google Scholar
• Plourde B, Sarrazin JF, Nault I, Poirier P. Sudden cardiac death and obesity. Expert Rev Cardiovasc Ther. 2014;12(9):1099–1110. doi:10.1586/14779072.2014.952283.
   PubMedGoogle Scholar
• Wittwer JA, Golden SH, Joseph JJ. Diabetes and CVD risk: Special considerations in African Americans related to care. Curr Cardiovasc Risk Rep. 2020;14(10):15. doi:10.1007/s12170-020-00648-2.
   Web of Science ®Google Scholar
• Hinchliffe N, Capehorn MS, Bewick M, Feenie J. The potential role of digital health in obesity care. Adv Ther. 2022;39(10):4397–4412. doi:10.1007/s12325-022-02265-4.
   PubMed Web of Science ®Google Scholar
• Anderson JE. Combining glucagon-like peptide 1 receptor agonists and sodium–glucose cotransporter 2 inhibitors to target multiple organ defects in type 2 diabetes. Diabetes Spectr. 2020;33(2):165–174. doi:10.2337/ds19-0031.
   PubMedGoogle Scholar
• Ferro EG, Elshazly MB, Bhatt DL. New antidiabetes medications and their cardiovascular and renal benefits. Cardiol Clin. 2021;39(3):335–351. doi:10.1016/j.ccl.2021.04.007.
   PubMed Web of Science ®Google Scholar
• Kuwabara A, Su S, Krauss J. Utilizing digital health technologies for patient education in lifestyle medicine. Am J Lifestyle Med. 2020;14(2):137–142. doi:10.1177/1559827619892547.
   PubMed Web of Science ®Google Scholar
• McGinnis JM, Fineberg HV, Dzau VJ. Advancing the learning health system. N Engl J Med. 2021;385(1):1–5. doi:10.1056/NEJMp2103872.
   PubMed Web of Science ®Google Scholar
• Marvel FA, Spaulding EM, Lee MA, et al. Digital health intervention in acute myocardial infarction. Circ Cardiovasc Qual Outcomes. 2021;14(7):e007741. doi:10.1161/CIRCOUTCOMES.121.007741.
   PubMed Web of Science ®Google Scholar
• Bhardwaj V, Spaulding EM, Marvel FA, et al. Cost-effectiveness of a digital health intervention for acute myocardial infarction recovery. Med Care. 2021;59(11):1023–1030. doi:10.1097/MLR.0000000000001636.
   PubMed Web of Science ®Google Scholar
• Lenfant T, Ravaud P, Montori VM, Berntsen GR, Tran VT. Five principles for the development of minimally disruptive digital medicine. BMJ. Published online December 19, 2023;2960. doi:10.1136/bmj.p2960.
   PubMedGoogle Scholar
• Alowais SA, Alghamdi SS, Alsuhebany N, et al. Revolutionizing healthcare: the role of artificial intelligence in clinical practice. BMC Med Educ. 2023;23(1):689. doi:10.1186/s12909-023-04698-z.
   PubMed Web of Science ®Google Scholar
• Irace C, Cutruzzolà A, Nuzzi A, et al. Clinical use of a 180‐day implantable glucose sensor improves glycated haemoglobin and time in range in patients with type 1 diabetes. Diabetes Obes Metab. 2020;22(7):1056–1061. doi:10.1111/dom.13993.
   PubMed Web of Science ®Google Scholar
• Davis GM, Hughes MS, Brown SA, et al. Automated insulin delivery with remote real-time continuous glucose monitoring for hospitalized patients with diabetes: A multicenter, single-arm, feasibility trial. Diabetes Technol Ther. 2023;25(10):677–688. doi:10.1089/dia.2023.0304.
   PubMed Web of Science ®Google Scholar
• Junaid SB, Imam AA, Balogun AO, et al. Recent advancements in emerging technologies for healthcare management systems: A survey. Healthcare. 2022;10(10):1940. doi:10.3390/healthcare10101940.
   Web of Science ®Google Scholar
• Sugandh F, Chandio M, Raveena F, et al. Advances in the management of diabetes mellitus: a focus on personalized medicine. Cureus. August 18, 2023;15(8). doi:10.7759/cureus.43697.
   Web of Science ®Google Scholar
• Haw JS, Galaviz KI, Straus AN, et al. Long-term sustainability of diabetes prevention approaches: A systematic review and meta-analysis of randomized clinical trials. JAMA Intern Med. 2017;177(12):1808. doi:10.1001/jamainternmed.2017.6040.
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. Standards of medical care in diabetes—2013. Diab Care. 2013;36(Supp_1):S11–S66. doi:10.2337/dc13-S011.
   PubMedGoogle Scholar
• Ziegler R, Heidtmann B, Hilgard D, et al. Frequency of SMBG correlates with HbA1c and acute complications in children and adolescents with type 1 diabetes. Pediatr Diabetes. 2011;12(1):11–17. doi:10.1111/j.1399-5448.2010.00650.x.
   PubMed Web of Science ®Google Scholar
• Miller KM, Beck RW, Bergenstal RM, et al. Evidence of a strong association between frequency of self-monitoring of blood glucose and hemoglobin A1c levels in T1D exchange clinic registry participants. Diab Care. 2013;36(7):2009–2014. doi:10.2337/dc12-1770.
   PubMed Web of Science ®Google Scholar
• Battelino T, Phillip M, Bratina N, Nimri R, Oskarsson P, Bolinder J. Effect of continuous glucose monitoring on hypoglycemia in type 1 diabetes. Diab Care. 2011;34(4):795–800. doi:10.2337/dc10-1989.
   PubMed Web of Science ®Google Scholar
• Vigersky RA, Fonda SJ, Chellappa M, Walker MS, Ehrhardt NM. Short- and long-term effects of real-time continuous glucose monitoring in patients with type 2 diabetes. Diab Care. 2012;35(1):32–38. doi:10.2337/dc11-1438.
   PubMed Web of Science ®Google Scholar
• Tejera-Pérez C, Chico A, Azriel-Mira S, et al. Connected Insulin pens and caps: An expert’s recommendation from the area of diabetes of the Spanish Endocrinology and Nutrition Society (SEEN). Diabetes Ther. 2023;14(7):1077–1091. doi:10.1007/s13300-023-01417-1.
   PubMed Web of Science ®Google Scholar
• Yoo JH, Kim JH. Advances in continuous glucose monitoring and integrated devices for management of diabetes with insulin-based therapy: improvement in glycemic control. Diabetes Metab J. 2023;47(1):27–41. doi:10.4093/dmj.2022.0271.
   PubMed Web of Science ®Google Scholar
• Home. GWAVE. https://www.hagartech.com/. Accessed March 1, 2024.
   Google Scholar
• Mayberry LS, Guy C, Hendrickson CD, McCoy AB, Elasy T. Rates and correlates of uptake of continuous glucose monitors among adults with type 2 diabetes in primary care and endocrinology settings. J Gen Intern Med. 2023;38(11):2546–2552. doi:10.1007/s11606-023-08222-3.
   PubMed Web of Science ®Google Scholar
• Zhao L, Liang C, Huang Y, et al. Emerging sensing and modeling technologies for wearable and cuffless blood pressure monitoring. NPJ Digit Med. 2023;6(1):93. doi:10.1038/s41746-023-00835-6.
   PubMed Web of Science ®Google Scholar
• Hare AJ, Chokshi N, Adusumalli S. Novel Digital Technologies for blood pressure monitoring and hypertension management. Curr Cardiovasc Risk Rep. 2021;15(8):11. doi:10.1007/s12170-021-00672-w.
   PubMed Web of Science ®Google Scholar
• Ko HYK, Tripathi NK, Mozumder C, Muengtaweepongsa S, Pal I. Real-time remote patient monitoring and alarming system for noncommunicable lifestyle diseases. Hu F, ed. Int J Telemed Appl. 2023;2023:1–13. doi:10.1155/2023/9965226.
   Web of Science ®Google Scholar
• Vora LK, Gholap AD, Jetha K, Thakur RRS, Solanki HK, Chavda VP. Artificial intelligence in pharmaceutical technology and drug delivery design. Pharmaceutics. 2023;15(7):1916. doi:10.3390/pharmaceutics15071916.
   PubMed Web of Science ®Google Scholar
• Omboni S, Gazzola T, Carabelli G, Parati G. Clinical usefulness and cost effectiveness of home blood pressure telemonitoring: meta-analysis of randomized controlled studies. J Hypertens. 2013;31(3):455–468. doi:10.1097/HJH.0b013e32835ca8dd.
   PubMed Web of Science ®Google Scholar
• Vybornova A, Polychronopoulou E, Wurzner-Ghajarzadeh A, Fallet S, Sola J. Wuerzner G.Blood pressure from the optical Aktiia Bracelet: a 1-month validation study using an extended ISO81060-2 protocol adapted for a cuffless wrist device. Blood Press Monit. 2021;26(4):305–311. doi:10.1097/MBP.0000000000000531.
   PubMed Web of Science ®Google Scholar
• Shan R, Ding J, Weng D, et al. Early blood pressure assessment after acute myocardial infarction: insights using digital health technology. Am J Prev Cardiol. 2020;3:100089. doi:10.1016/j.ajpc.2020.100089.
   PubMedGoogle Scholar
• Konstantinidis D, Iliakis P, Tatakis F, et al. Wearable blood pressure measurement devices and new approaches in hypertension management: the digital era. J Hum Hypertens. 2022;36(11):945–951. doi:10.1038/s41371-022-00675-z.
   PubMed Web of Science ®Google Scholar
• Commodore-Mensah Y, Liu X, Ogungbe O, et al. Design and rationale of the home blood pressure telemonitoring Linked with Community Health Workers to Improve Blood Pressure (LINKED-BP) program. Am J Hypertens. 2023;36(5):273–282. doi:10.1093/ajh/hpad001.
   PubMed Web of Science ®Google Scholar
• Sphygmo. Sphygmobp.com. https://app.sphygmobp.com. Published 2023. Accessed December 6, 2023.
   Google Scholar
• Validate BP. www validatebp.org. https://www.validatebp.org. Published 2023. Accessed October 2, 2023.
   Google Scholar
• Ibrahim B, Jafari R. Cuffless blood pressure monitoring from a wristband with calibration-free algorithms for sensing location based on bio-impedance sensor array and autoencoder. Sci Rep. 2022;12(1):319. doi:10.1038/s41598-021-03612-1.
   PubMed Web of Science ®Google Scholar
• Bajraktari F, Liu J, Pott PP. Methods of Contactless Blood Pressure Measurement: A Systematic Review. Curr Dir Biomed Eng. 2022;8(2):439–442. doi:10.1515/cdbme-2022-1112.
   Google Scholar
• Riddell MC, Pooni R, Fontana FY, Scott SN. Diabetes Technology and Exercise. Endocrinol Metab Clin North Am. 2020;49(1):109–125. doi:10.1016/j.ecl.2019.10.011.
   PubMed Web of Science ®Google Scholar
• Bassett DR, Toth LP, LaMunion SR, Crouter SE. Step Counting: A Review of Measurement Considerations and Health-Related Applications. Sports Med. 2017;47(7):1303–1315. doi:10.1007/s40279-016-0663-1.
   PubMed Web of Science ®Google Scholar
• Garduno AC, LaCroix AZ, LaMonte MJ, et al. Associations of Daily Steps and Step Intensity With Incident Diabetes in a Prospective Cohort Study of Older Women: The OPACH Study. Diab Care. 2022;45(2):339–347. doi:10.2337/dc21-1202.
   PubMed Web of Science ®Google Scholar
• Fitbit Official Site for Activity Trackers & More. Fitbit.com. http://www.fitbit.com. Published 2018. Accessed September 2023.
   Google Scholar
• Smith C. Nike FuelBand: The rise and fall of the wearable that started it all. Wareable. https://www.wareable.com/fitness-trackers/not-so-happy-birthday-nike-fuelband-2351. Published March 14, 2018. Accessed October 2, 2023.
   Google Scholar
• Activity Monitors. www omron-healthcare.com. https://www.omron-healthcare.com/activity-monitors. Published 2023. Accessed December 1, 2023.
   Google Scholar
• Apple. Watch. Apple. https://www.apple.com/watch/. Published 2023. Accessed November 14, 2023.
   Google Scholar
• Kamel Boulos MN, Yang SP. Mobile physical activity planning and tracking: a brief overview of current options and desiderata for future solutions. Mhealth. 2021;7:13–13. doi:10.21037/mhealth.2020.01.01.
   PubMedGoogle Scholar
• Hughes A, Shandhi MMH, Master H, Dunn J, Brittain E. Wearable Devices in Cardiovascular Medicine. Circ Res. 2023;132(5):652–670. doi:10.1161/CIRCRESAHA.122.322389.
   PubMed Web of Science ®Google Scholar
• Sitges C, Terrasa JL, García-Dopico N, et al. An Educational and Exercise Mobile Phone–Based Intervention to Elicit Electrophysiological Changes and to Improve Psychological Functioning in Adults With Nonspecific Chronic Low Back Pain (BackFit App): Nonrandomized Clinical Trial. JMIR mHealth uhealth. 2022;10(3):e29171. doi:10.2196/29171.
   PubMed Web of Science ®Google Scholar
• Wilke J, Mohr L, Yuki G, et al. Train at home, but not alone: a randomised controlled multicentre trial assessing the effects of live-streamed tele-exercise during COVID-19-related lockdowns. Br J Sports Med. 2022;56(12):667–675. doi:10.1136/bjsports-2021-104994.
   PubMed Web of Science ®Google Scholar
• Vasselli JR, Juray S, Trasino SE. Success and failures of telehealth during COVID‐19 should inform digital applications to combat obesity. Obes Sci Pract. 2022;8(2):254–258. doi:10.1002/osp4.551.
   PubMed Web of Science ®Google Scholar
• Peng W, Kanthawala S, Yuan S, Hussain SA. A qualitative study of user perceptions of mobile health apps. BMC Public Health. 2016;16(1):1158. doi:10.1186/s12889-016-3808-0.
   PubMed Web of Science ®Google Scholar
• Scherenberg and Kramer. Transferring the established health definition of the WHO from 1946, health apps can be described as mobile applications that aim to positively and sustainably influence physical, mental and social well-being on the basis of scientific evidence”.
   Google Scholar
• Eberle C, Löhnert M, Stichling S. Effectiveness of Disease-Specific mHealth Apps in Patients With Diabetes Mellitus: Scoping Review. JMIR mHealth uhealth. 2021;9(2):e23477. doi:10.2196/23477.
   PubMed Web of Science ®Google Scholar
• Georga EI, Protopappas VC, Bellos CV, Fotiadis DI. Wearable systems and mobile applications for diabetes disease management. Health Technol. 2014;4(2):101–112. doi:10.1007/s12553-014-0082-y.
   Google Scholar
• mySugr US - Make Diabetes Suck Less. www mysugr.com. https://www.mysugr.com/. Published 2020. Accessed December 6, 2023.
   Google Scholar
• Glucose Buddy. www glucosebuddy.com. https://www.glucosebuddy.com. Published 2019. Accessed December 6, 2023.
   Google Scholar
• Diabetes:M - Your Diabetes Management App - Keep Diabetes Under Control. Diabetes: M- Your Diabetes Management App. https://diabetesm.com. Published 2017. Accessed October 1, 2023.
   Google Scholar
• Remote patient monitoring for diabetes and related chronic conditions. Glooko. https://glooko.com/. Published March, 2021. Accessed November 10, 2023.
   Google Scholar
• Felker GM, Sharma A, Mentz RJ, et al. A Randomized Controlled Trial of Mobile Health Intervention in Patients With Heart Failure and Diabetes. J Card Fail. 2022;28(11):1575–1583. doi:10.1016/j.cardfail.2022.07.048.
   PubMed Web of Science ®Google Scholar
• Or C, Tao D. A 3-Month randomized controlled pilot trial of a patient-centered, computer-based self-monitoring system for the care of type 2 diabetes mellitus and hypertension. J Med Syst. 2016;40(4):81. doi:10.1007/s10916-016-0437-1.
   PubMed Web of Science ®Google Scholar
• Yoo HJ, Park MS, Kim TN, et al. A ubiquitous chronic disease care system using cellular phones and the internet. Diabet Med. 2009;26(6):628–635. doi:10.1111/j.1464-5491.2009.02732.x.
   PubMed Web of Science ®Google Scholar
• Zhong J, Zhang H, Li Z, et al. Effect of social app-assisted education and support on glucose control in patients with coronary heart disease and diabetes mellitus. Front Cardiovasc Med. 2022;9:947130. doi:10.3389/fcvm.2022.947130.
   PubMedGoogle Scholar
• McCarthy J, Minsky ML, Rochester N, Shannon CE. A Proposal for the Dartmouth Summer Research Project on Artificial Intelligence. AI Magazine. 2006;27(4):12. doi:10.1609/aimag.v27i4.1904. August 31, 1955.
   Web of Science ®Google Scholar
• Samuel AL. Some studies in machine learning using the game of checkers (Reprinted from Journal of Research and Development, vol 3, 1959. IBM J Res & Dev. 2000;44(1.2):206–226. doi:10.1147/rd.441.0206.
   Web of Science ®Google Scholar
• Dankwa-Mullan I, Rivo M, Sepulveda M, Park Y, Snowdon J, Rhee K. Transforming Diabetes Care Through Artificial Intelligence: The Future Is Here. Popul Health Manag. 2019;22(3):229–242. doi:10.1089/pop.2018.0129.
   PubMed Web of Science ®Google Scholar
• Pyrros A, Borstelmann SM, Mantravadi R, et al. Opportunistic detection of type 2 diabetes using deep learning from frontal chest radiographs. Nat Commun. 2023;14(1):4039. doi:10.1038/s41467-023-39631-x.
   PubMed Web of Science ®Google Scholar
• Najafi B, Mishra R. harnessing digital health technologies to remotely manage diabetic foot syndrome: a narrative review. Medicina (B Aires). 2021;57(4):377. doi:10.3390/medicina57040377.
   Google Scholar
• Javaid A, Zghyer F, Kim C, et al. Medicine 2032: The future of cardiovascular disease prevention with machine learning and digital health technology. Am J Prev Cardiol. 2022;12:100379. doi:10.1016/j.ajpc.2022.100379.
   PubMedGoogle Scholar
• Wu Y, Min H, Li M, et al. Effect of Artificial Intelligence-based Health Education Accurately Linking System (AI-HEALS) for Type 2 diabetes self-management: protocol for a mixed-methods study. BMC Public Health. 2023;23(1):1325. doi:10.1186/s12889-023-16066-z.
   PubMed Web of Science ®Google Scholar
• Chronic disease reversal, improvement, and prevention. Twin Health. https://www.usa.twinhealth.com. Published 2013. Accessed December 2, 2023.
   Google Scholar
• Artificial Intelligence Offers Significant Rate of Remission for Type 2 Diabetes Compared to Standard Care | ADA. www2.diabetes.org. https://diabetes.org/newsroom/press-releases/2022/artificial-intelligence-offers-significant-rate-remission-type-2-diabetes-compared-to-standard-care. Published June 2022. Accessed December 11, 2023.
   Google Scholar
• Artificial intelligence: the next frontier in diabetes therapy. wwwnaturecom. https://www.nature.com/articles/d42473-021-00265-6
   Google Scholar
• Yang WE, Spaulding EM, Lumelsky D, et al. Strategies for the Successful Implementation of a Novel iPhone Loaner System (iShare) in mHealth Interventions: Prospective Study. JMIR mHealth uhealth. 2019;7(12):e16391. doi:10.2196/16391.
   PubMed Web of Science ®Google Scholar
• Haleem A, Javaid M, Singh RP, Suman R. Telemedicine for healthcare: Capabilities, features, barriers, and applications. Sensors Int. 2021;2:100117. doi:10.1016/j.sintl.2021.100117.
   PubMedGoogle Scholar
• Wilson H. What are Currently the Biggest Challenges in Digital Health? The Journal of mHealth. https://thejournalofmhealth.com/what-are-currently-the-biggest-challenges-in-digital-health/. Published February 3, 2023. Accessed March 4, 2024.
   Google Scholar
• Paul M, Maglaras L, Ferrag MA, Almomani I. Digitization of healthcare sector: a study on privacy and security concerns. ICT Express. 2023;9(4):571–588. doi:10.1016/j.icte.2023.02.007.
   Web of Science ®Google Scholar
• IBM. IBM Report: Half of breached organizations unwilling to increase security spend despite soaring breach costs. IBM Newsroom. https://newsroom.ibm.com/2023-07-24-IBM-Report-Half-of-Breached-Organizations-Unwilling-to-Increase-Security-Spend-Despite-Soaring-Breach-Costs. Published July 24, 2023. Accessed February 29, 2024.
   Google Scholar
• Kerr D, Klonoff DC, Bergenstal RM, Choudhary P, Ji L. A roadmap to an equitable digital diabetes ecosystem. Endocr Pract. 2023;29(3):179–184. doi:10.1016/j.eprac.2022.12.016.
   PubMed Web of Science ®Google Scholar